CMS certification 190111
Willis Knighton Medical Center
2600 Greenwood Road, Shreveport, LA 71103
Willis Knighton Medical Center has a CMS overall rating of 3 out of 5 stars. 72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 1. Emergency patients spend a median of 2 h 57 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,476 completed surveys, 17% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | LA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 1,723 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 57 min | 2 h 9 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 58 visits sampled | 3 h 58 min | 3 h 54 min | 4 h 17 min |
| Left before being seen Lower is better · 151,852 patients | 4% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 28 patients | 61% | 70% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 2,347 patients | 66% | 69% | 65% |
How Willis Knighton Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Willis Knighton Medical CenterThis hospital | 3/5 | 72% | 2 h 57 min | 2 better 1 worse |
| CHRISTUS Shreveport-Bossier Health SystemSame city | 3/5 | 71% | 2 h 45 min | 3 better 2 worse |
| Ochsner LSU Health Shreveport-St Mary Medical CentSame city | 2/5 | 75% | — | 1 better |
| Overton Brooks VA Medical Center (shreveport)Same city | 2/5 | 67% | — | 2 worse |
| Specialists Hospital ShreveportSame city | Not rated | 82% | — | 1 better |
| Ochsner LSU Health ShreveportSame city | 2/5 | 69% | 4 h 7 min | 4 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Shreveport.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 7,514 cases | Too few cases | 5.5% | 3.9% |
| Heart attack 328 cases | Too few cases | 11.7% | 11.9% |
| Heart failure 935 cases | Too few cases | 11.1% | 11.1% |
| Pneumonia 1,084 cases | Too few cases | 17% | 15.2% |
| Stroke 655 cases | Too few cases | 15.7% | 11.9% |
| COPD 474 cases | Too few cases | 9.6% | 8.6% |
| Heart bypass surgery (CABG) 164 cases | Too few cases | 4.7% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.96 likely 0.75 – 1.17 | 1 |
| After hip or knee replacement 86 cases | Too few cases | 4.1% | 4.1% |
| Deaths after a serious but treatable surgical complication 231 cases | No different | 187.83 per 1,000 likely 149.85 per 1,000 – 225.8 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 13,808 cases | No different | 0.4 per 1,000 likely 0 per 1,000 – 0.85 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 16,900 cases | No different | 0.18 per 1,000 likely 0.01 per 1,000 – 0.35 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 16,837 cases | No different | 0.32 per 1,000 likely 0.15 per 1,000 – 0.49 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,631 cases | No different | 1.72 per 1,000 likely 0.53 per 1,000 – 2.91 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,888 cases | No different | 1.8 per 1,000 likely 0.48 per 1,000 – 3.12 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 2,078 cases | No different | 10.9 per 1,000 likely 7.49 per 1,000 – 14.31 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,700 cases | No different | 2.7 per 1,000 likely 1.13 per 1,000 – 4.28 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,759 cases | No different | 5.95 per 1,000 likely 3.4 per 1,000 – 8.5 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 1,007 cases | No different | 1.86 per 1,000 likely 0.53 per 1,000 – 3.19 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,857 cases | No different | 0.89 per 1,000 likely 0.09 per 1,000 – 1.7 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.88 likely 0.56 – 1.3 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.78 likely 0.53 – 1.11 | 1 |
| Surgical site infections after colon surgery | No different | 0.93 likely 0.45 – 1.7 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 1.2 likely 0.3 – 3.25 | 1 |
| MRSA bloodstream infections | No different | 0.99 likely 0.56 – 1.62 | 1 |
| C. diff intestinal infections | Better | 0.57 likely 0.43 – 0.75 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 448 cases | Too few cases | 14.7% | 14.4% |
| Readmitted after heart failure 1,510 cases | Too few cases | 20.3% | 21.3% |
| Readmitted after pneumonia 1,366 cases | Too few cases | 16.6% | 17.3% |
| Readmitted after COPD 706 cases | Too few cases | 19% | 20% |
| Readmitted after heart bypass surgery 200 cases | Too few cases | 13.3% | 11% |
| Readmitted after hip or knee replacement 77 cases | Too few cases | 5% | 5.8% |
| Days back in hospital after a heart attack 340 cases | Too few cases | 6.4 days per 100 | — |
| Days back in hospital after heart failure 1,102 cases | Too few cases | -2.7 days per 100 | — |
| Days back in hospital after pneumonia 1,101 cases | Too few cases | 14.1 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,555 cases | No different | 12.3 per 1,000 likely 9.6 per 1,000 – 15.8 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 466 cases | No different | 11.2 per 100 likely 9.4 per 100 – 13.4 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 466 cases | No different | 5.2 per 100 likely 4 per 100 – 6.8 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,259 cases | No different | 0.8 likely 0.7 – 1 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
94 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 53 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Nurse Anesthetist, Certified Registered | 34 |
| Diagnostic Radiology | 15 |
| Emergency Medicine | 9 |
| Acute Care | 8 |
| Anesthesiology | 7 |
| Critical Care Medicine | 4 |
| Internal Medicine | 3 |
| Family | 2 |
| Registered Nurse | 2 |
| Surgery | 2 |
| Neonatal | 1 |
| Nurse Practitioner | 1 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $117,168
- 2020 $130,516
- 2021 $159,383
- 2022 $709,743
- 2023 $120,074
- 2024 $485,903
- 2025 $390,151
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $75,000 | 4 |
| Speaking, teaching and other services | $4,333 | 5 |
| Medical devices and supplies on long-term loan | $2,743 | 4 |
| Space rental and facility fees | $2,600 | 1 |
| Debt forgiveness | $931 | 5 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | $115,695 | 4 |
| KLS-Martin L.P. | $75,000 | 4 |
| Abbvie INC. | $74,746 | 14 |
| AstraZeneca AB | $27,206 | 1 |
| Celgene Corporation | $19,000 | 1 |
| Rapid Medical Ltd | $16,500 | 1 |
| Bluewind Medical | $15,470 | 15 |
| AstraZeneca UK Limited | $13,472 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Randomized 2-cohort Double-blind Placebo-controlled Phase III Study of AZD5305 in Combination with Physicians Choice New Hormonal Agents in Patient… AstraZeneca Pharmaceuticals LP | $46,165 |
| A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Dur… AstraZeneca Pharmaceuticals LP | $42,929 |
| A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared … ABBVIE INC. · NCT06880744 | $42,487 |
| A Phase III Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis in Pediatric Patients 1 to 11 Years o… AstraZeneca AB | $27,206 |
| A PHASE 3, TWO-STAGE, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY COMPARING MEZIGDOMIDE (CC-92480), BORTEZOMIB AND DEXAMETHASONE (MEZIVd) VERSUS POMALI… Celgene Corporation | $19,000 |
| Cognitive Rapid Medical Ltd · NCT05531461 | $16,500 |
| A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused … ABBVIE INC. · NCT06428019 | $15,500 |
| RESTORE: AN RCT TO EVAULATE THE EFFICACY OF THE REVI SYSTEM BLUEWIND MEDICAL · NCT06217328 | $15,470 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Willis Knighton Medical Center
Is Willis Knighton Medical Center a good hospital?
Willis Knighton Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Willis Knighton Medical Center?
72% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,476 completed HCAHPS surveys.
How long is the wait in the Willis Knighton Medical Center emergency room?
Emergency patients spend a median of 2 h 57 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 4% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Willis Knighton Medical Center receive money from drug and device companies?
Drug and device makers reported $390,151 in payments to Willis Knighton Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.